BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//New Jersey Alliance for Clinical and Translational Science - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:New Jersey Alliance for Clinical and Translational Science
X-ORIGINAL-URL:https://njacts.rbhs.rutgers.edu
X-WR-CALDESC:Events for New Jersey Alliance for Clinical and Translational Science
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250205T110000
DTEND;TZID=America/New_York:20250205T120000
DTSTAMP:20260405T074510
CREATED:20250109T165828Z
LAST-MODIFIED:20250109T170354Z
UID:42827-1738753200-1738756800@njacts.rbhs.rutgers.edu
SUMMARY:CSL Research Acceleration Initiative Webinar
DESCRIPTION:CSL Research Acceleration Initiative Webinar-Fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations\, receive funding of up to $400\,000 USD over 2 years. Deadline to submit a non-confidential 300 words abstract is 2/20. All Rutgers researchers contact Pragati Sharma or their licensing managers to ensure that the information submitted to the company is non-confidential. View Flyer and Join Webinar In Teams 
URL:https://njacts.rbhs.rutgers.edu/event/csl-research-acceleration-initiative-webinar-2/
LOCATION:NJ
END:VEVENT
END:VCALENDAR